CAS: 1206163-45-2
Solcitinib
CAS:1206163-45-2
Solcitinib (GLPG-0778), a JAK1 inhibitor, may treat psoriasis, ulcerative colitis, and lupus.
Formula:
C22H23N5O2
Purity:
98.25% - 99.82%
Color and Shape:
Solid
Molecular weight:
389.45
Ref: TM-T3620
| 5mg | 50.00 € | ||
| 10mg | 62.00 € | ||
| 25mg | 88.00 € | ||
| 50mg | 113.00 € | ||
| 100mg | 181.00 € | ||
| 200mg | 291.00 € | ||
| 1mL*10mM (DMSO) | 50.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
![N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanec…](https://static.cymitquimica.com/products/10/thumb/F497231.jpg)
N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
CAS:1206163-45-2
Purity:
95.0%
Molecular weight:
389.4590148925781
Ref: 10-F497231
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Solcitinib
CAS:1206163-45-2
Solcitinib is a Jak1 inhibitor that is being evaluated for its potential to treat cancer. …
Formula:
C22H23N5O2
Purity:
Min. 95%
Molecular weight:
389.45 g/mol
Ref: 3D-GYB16345
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
